Sign in
4

Changes in Ownership

Maze Therapeutics, Inc. Filed Acc 0000950170-25-013760

10% owner acquired 6,713,588 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Third Rock Ventures IV, L.P. · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-03 Conversion : show line 1 in the form +5,762,788 6,073,958 D
2025-02-03 Conversion : show line 2 in the form +950,800 950,800 I

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-02-03 Conversion : show line 3 in the form Series A Preferred Stock −45,833,334 0 D
2025-02-03 Conversion : show line 4 in the form Series D-1 Preferred Stock −9,725,709 0 D
2025-02-03 Conversion : show line 5 in the form Series A Preferred Stock −9,166,666 0 I
Loading xslF345X05/ownership.xml…